Another way to avoid having to make a corrigendum is to ensure that all co-authors are happy with the original submission, the resubmission and the proofs (i.e
Rosa, L., Cutone, A., Lepanto, M
Warburg O, Wind F, Negelein E
Potency compared to BDNF In preclinical research, Dihexa has been described as potentially millions of times more potent than BDNF (brain-derived neurotrophic factor) in driving synapse growth
(1991) documented that IV infusion of 2 g/m^2 raised plasma glutathione from 17.5 umol/L to 823 umol/L -- a roughly 47-fold increase -- with a half-life of approximately 14 minutes (Aebi et al., 1991)
[7] [8] This triple-receptor mechanism distinguishes it from existing approved agents such as semaglutide (a GLP-1 agonist) or tirzepatide (a dual GLP-1/GIP agonist)